Image

Study to Evaluate the Performance and Safety of ATF Implants and Lapé Médical Devices Implanted During Hip Arthroplasty

Recruiting
years of age
Both
Phase N/A

Powered by AI

Overview

Observational and prospective multicenter study to evaluate the long-term (10 years) performance and safety (10 years) of ATF Implants and Lapé Médical devices implanted during total hip arthroplasty or hemiarthroplasty.

Description

Observational and prospective multicenter study to evaluate the long-term (10 years) performance and safety (10 years) of ATF Implants and Lapé Médical devices implanted during total hip arthroplasty or hemiarthroplasty.

The post-market clinical follow-up study to be conducted by ATF Implants following this plan aims to collect data from the follow-up of patients before and after hip replacement surgery with implants manufactured by ATF Implants and Lapé médical. In current practice, the surgeon-investigator evaluates the patient pre- and post-operatively according to predefined criteria used in orthopedic surgery and more particularly in hp replacement surgery. Complications and adverse effects observed are also recorded.

The main objective is to gather clinical evidence to evaluate the survival rate of ATP Implants and Lapé médical hip prostheses over the long-term, namely 10 years.

The secondary objectives are to evaluate the performance and safety of the prostheses over the same period (i.e. 10 years), as well as to obtain feedback on the performance /intended use and safety of the surgical instruments required for implant placement.

Eligibility

Inclusion Criteria:

  • Male or female indicated for hip replacement surgery with hip prosthesis manufactured by ATF Implants and/or Lapé médical;
        There are different indications for hip replacement surgery. The main ones are listed
        below:
          -  Dysplasia
          -  Primary Coxarthrosis
          -  Secondary Coxarthrosis
          -  Perthes disease
          -  Epiphysiolysis
          -  Ankylosing spondylitis
          -  Trochanteric bursitis
          -  Arthritis
          -  Degenerative arthritis
          -  Post-traumatic arthritis
          -  Rheumatoid arthritis
          -  Femoral neck fracture
          -  Osteonecrosis
          -  Revision
        Depending on the specificities of the devices (size, absence/presence of a coating,
        material), indications may vary. This information can be found in the instruction for use.
        It is the surgeon's responsibility to select the most appropriate prosthesis for a given
        patient according to the patient's medical records and the instruction for use in force at
        the time of the procedure accompanying the medical device.
        Exclusion Criteria:
          -  There are various contraindications for hip arthroplasty. The main ones are listed
             below:
               -  An acute or chronic, local or systemic infection
               -  Severe muscular, neurological or vascular deficiency compromising the affected
                  extremity
               -  A bone defect or insufficient bone quality that may compromise the stability of
                  the implant
               -  Any concomitant disease (dysplastic coxarthrosis with extreme coxa valga, short
                  neck and severe varus) that may affect the function of the implant
               -  Sensitivity to the material (allergy) Depending on the specificities of the
                  devices (size, absence/presence of a coating, material), contraindications may
                  vary. This information can be found in the instruction for use of the devices.

Study details

Arthroplasty, Hip, Replacement

NCT05044767

ATF Implants

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.